FINDINGS OF SCIENTIFIC MISCONDUCT NIH GUIDE, Volume 26, Number 15, May 9, 1997 P.T. 34 Keywords: Ethics/Values in Science & Technol Grants Administration/Policy+ Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following cases: Ann Marie Huelskamp, M.H.S., The Johns Hopkins University School of Medicine: Based upon a report forwarded to the Office of Research Integrity (ORI) by The Johns Hopkins University School of Medicine, information obtained by ORI during its oversight review, and Ms. Huelskamp\~s own admission, ORI found that Ms. Huelskamp, a research program coordinator in the Oncology Center, The Johns Hopkins University School of Medicine, engaged in scientific misconduct by fabricating patient interview data for a study of quality of life measures in cancer patients. The research was supported by a grant from the National Cancer Institute (NCI), National Institutes of Health (NIH). ORI also found that Ms. Huelskamp engaged in scientific misconduct by falsifying patient status data by failing to update the status of treated breast cancer patients and misrepresenting data from previous contacts as the updated status for a study. These data were reported in a grant application to NCI and gave the appearance that some patients\~ outcomes were more favorable than they actually were. Ms. Huelskamp cooperated fully with the Johns Hopkins investigation. The investigation report acknowledged her excessive workload, the difficulties associated with recruiting and following up on patients, and a lack of supervisory oversight. Ms. Huelskamp has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which she has voluntarily agreed, for the three (3) year period beginning April 17, 1997: (1) to exclude herself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) that any institution that submits an application for PHS support for a research project on which Ms. Huelskamp\~s participation is proposed or which uses her in any capacity on PHS-supported research must concurrently submit a plan for supervision of her duties. The supervisory plan must be designed to ensure the scientific integrity of Ms. Huelskamp\~s research contribution. The institution must submit a copy of the supervisory plan to ORI. No scientific publications were required to be corrected as part of this Agreement. William G. McCown, Ph.D., Integra, Inc.: Based upon a report forwarded to the Office of Research Integrity (ORI) by Compass Information Services, Inc., and information obtained by ORI during its oversight review, ORI found that Dr. McCown, former Project Director at Integra, Inc. (now Compass Information Services, Inc.), engaged in scientific misconduct by falsifying answer sheets for an \~Item Count Substance Abuse Survey\~ supported by a grant from the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). Dr. McCown has entered into a Voluntary Exclusion Agreement with ORI in which he does not admit to any acts of scientific misconduct but has voluntarily agreed, for the three (3) year period beginning April 17, 1997: (1) to exclude himself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) that any institution that submits an application for PHS support for a research project on which Dr. McCown\~s participation is proposed or which uses him in any capacity on PHS supported research must concurrently submit a plan for supervision of his duties. The supervisory plan must be designed to ensure the scientific integrity of Dr. McCown\~s research contribution. The institution must submit a copy of the supervisory plan to ORI. No scientific publications were required to be corrected as part of this Agreement. Weidong Sun, M.D., Ph.D., Medical College of Pennsylvania and Hahnemann University: Based upon a report forwarded to the Office of Research Integrity (ORI) by the Medical College of Pennsylvania and Hahnemann University as well as information obtained by ORI during its oversight review, ORI found that Dr. Sun, a former graduate student in the Department of Physiology, Medical College of Pennsylvania and Hahnemann University, engaged in scientific misconduct by falsifying data in conducting and reporting research supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH). The research also was reported in applications requesting funding from NIAMS and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. Specifically, Dr. Sun falsified data by misrepresenting cloned DNA sequences from chicken non-muscle myosin as an isoform of neuronal myosin II from rat brain. The falsified cDNA was included in the following publications and nucleotide sequences in GenBank and EMBL databases: o Sun, W.D., & Chantler, P.D. \~Cloning of the cDNA encoding a neuronal myosin heavy chain from mammalian brand and its differential expression within the central nervous system.\~ Journal of Molecular Biology 224(4):1185-1193, 1992; o Sun, W.D., & Chantler, P.D. \~A unique cellular myosin II exhibiting differential expression in the cerebral cortex.\~ Biochemical and Biophysical Research Communications 175(1):244-249, 1991; o Sun, W., Chen, X., & Chantler, P.D. \~Inhibition of neuritogenesis by antisense arrest of the expression of a specific isoform of brain myosin II.\~ Journal of Muscle Research and Cell Motility 15:184-185, 1994; om M64596, \~Rat myosin II mRNA, 3\' end.\~ \[RETMYOSII\]; o M80591, \~Rat neuronal myosin heavy chain mRNA, 3\' end.\~ \[RATMYOH3E\]; o M94962, \~Rattus rattus neuronal myosin heavy chain gene promoter sequence.\~ \[RATMYOPRO\]; and o X62659, S98128, \~R.rattus MRNA for brain neuronal myosin heavy chain.\~ \[RRNMYOHC\]. Retractions of the publications and deletions from the public data banks have been requested. Dr. Sun has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed, for the three (3) year period beginning April 17, 1997: (1) to exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 C.F.R. Part 76 (Debarment Regulations); and (2) to exclude himself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. INQUIRIES For further information contact: Acting Director, Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330 .
